Sanofi Consumer Healthcare India Ltd Upgraded to Hold on Technical and Financial Improvements
2026-05-19 09:09:09Sanofi Consumer Healthcare India Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved technical outlook and positive financial trends. The company’s robust quarterly results, strong management efficiency, and net-debt-free status have contributed to this reassessment, despite some concerns over valuation and long-term growth. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the recent rating change.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
30-Jul-2026 | Source : BSECopy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
28-Jul-2026 | Source : BSEThe Board of Directors at its meeting held on Tuesday 28th July 2026 considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this regard please find enclosed a press release.
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 28Th July 2026
28-Jul-2026 | Source : BSEWe wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday 28th July 2026 inter alia considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026.
Corporate Actions
No Upcoming Board Meetings
Sanofi Consumer Healthcare India Ltd has declared 750% dividend, ex-date: 19 Jun 26
No Splits history available
No Bonus history available
No Rights history available